BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10982966)

  • 1. Terminal osseous dysplasia and pigmentary defects: clinical characterization of a novel male lethal X-linked syndrome.
    Bacino CA; Stockton DW; Sierra RA; Heilstedt HA; Lewandowski R; Van den Veyver IB
    Am J Med Genet; 2000 Sep; 94(2):102-12. PubMed ID: 10982966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Terminal osseous dysplasia with pigmentary defects (TODPD): Follow-up of the first reported family, characterization of the radiological phenotype, and refinement of the linkage region.
    Brunetti-Pierri N; Lachman R; Lee K; Leal SM; Piccolo P; Van Den Veyver IB; Bacino CA
    Am J Med Genet A; 2010 Jul; 152A(7):1825-31. PubMed ID: 20583181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Terminal osseous dysplasia with pigmentary defects: clinical description of a new family.
    Baroncini A; Castelluccio P; Morleo M; Soli F; Franco B
    Am J Med Genet A; 2007 Jan; 143A(1):51-7. PubMed ID: 17152064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical manifestations of terminal osseous dysplasia and pigmentary defects in a young girl.
    Lin BP; Lin MI; Berlocher WC
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 May; 95(5):607-13. PubMed ID: 12738953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Terminal osseous dysplasia with pigmentary defects maps to human chromosome Xq27.3-xqter.
    Zhang W; Amir R; Stockton DW; Van Den Veyver IB; Bacino CA; Zoghbi HY
    Am J Hum Genet; 2000 Apr; 66(4):1461-4. PubMed ID: 10739772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Terminal osseous dysplasia with pigmentary defects (TODPD) in a Turkish girl with new skin findings.
    Azakli H; Akkaya AD; Aygün MS; Demirkesen C; Eraslan S; Kayserili H
    Am J Med Genet A; 2019 Jan; 179(1):123-129. PubMed ID: 30561107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Terminal osseous dysplasia is caused by a single recurrent mutation in the FLNA gene.
    Sun Y; Almomani R; Aten E; Celli J; van der Heijden J; Venselaar H; Robertson SP; Baroncini A; Franco B; Basel-Vanagaite L; Horii E; Drut R; Ariyurek Y; den Dunnen JT; Breuning MH
    Am J Hum Genet; 2010 Jul; 87(1):146-53. PubMed ID: 20598277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anetoderma in a patient with terminal osseous dysplasia with pigmentary defects.
    Connor CJ; Shchelochkov OA; Ciliberto H
    Am J Med Genet A; 2015 Oct; 167A(10):2459-62. PubMed ID: 26059211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Terminal osseous dysplasia presenting with intracytoplasmic inclusion bodies in digital fibromas.
    Gontijo JRV; Dos Santos WF; Gontijo B; Happle R
    Pediatr Dermatol; 2018 Nov; 35(6):e353-e356. PubMed ID: 30168171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Terminal osseous dysplasia with pigmentary defects in a Chinese girl with the FLNA mutation: A case report and published work review.
    Li Z; Xie Y; Xiao Q; Wang L
    J Dermatol; 2020 Mar; 47(3):295-299. PubMed ID: 31919883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninclusion-body infantile digital fibromatosis: a lesion heralding terminal osseous dysplasia and pigmentary defects syndrome.
    Drut R; Pedemonte L; Rositto A
    Int J Surg Pathol; 2005 Apr; 13(2):181-4. PubMed ID: 15864382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infantile lethal variant of Simpson-Golabi-Behmel syndrome associated with hydrops fetalis.
    Terespolsky D; Farrell SA; Siegel-Bartelt J; Weksberg R
    Am J Med Genet; 1995 Nov; 59(3):329-33. PubMed ID: 8599356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Terminal osseous dysplasia with pigmentary defects and cardiomyopathy caused by a novel FLNA variant.
    Rumping L; Wessels MW; Postma AV; van Schuppen J; van Slegtenhorst MA; Saris JJ; van Tintelen JP; Robertson SP; Alders M; Maas SM; Deprez RHL
    Am J Med Genet A; 2021 Dec; 185(12):3814-3820. PubMed ID: 34254723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adams-Oliver syndrome revisited.
    Whitley CB; Gorlin RJ
    Am J Med Genet; 1991 Sep; 40(3):319-26. PubMed ID: 1951437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anonychia and absence/hypoplasia of distal phalanges (Cooks syndrome): report of a second family.
    Nevin NC; Thomas PS; Eedy DJ; Shepherd C
    J Med Genet; 1995 Aug; 32(8):638-41. PubMed ID: 7473658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. X-linked dominant inherited diseases with lethality in hemizygous males.
    Wettke-Schäfer R; Kantner G
    Hum Genet; 1983; 64(1):1-23. PubMed ID: 6873941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent digital fibroma, focal dermal hypoplasia, and limb malformations.
    Breuning MH; Oranje AP; Langemeijer RA; Hovius SE; Diepstraten AF; den Hollander JC; Baumgartner N; Dwek JR; Sommer A; Toriello H
    Am J Med Genet; 2000 Sep; 94(2):91-101. PubMed ID: 10982965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart-hand syndrome II. A report of Tabatznik syndrome with new findings.
    Silengo MC; Biagioli M; Guala A; Lopez-Bell G; Lala R
    Clin Genet; 1990 Aug; 38(2):105-13. PubMed ID: 1976459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. X-linked short stature with skin pigmentation: evidence for heterogeneity of the Russell-Silver syndrome.
    Partington MW
    Clin Genet; 1986 Feb; 29(2):151-6. PubMed ID: 3955866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terminal osseous dysplasia with pigmentary defects; Case and brief review of filamin A-related disorders.
    Bhabha FK; Walsh M; Orchard D; Savarirayan R
    Australas J Dermatol; 2016 Nov; 57(4):312-315. PubMed ID: 26061098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.